| Glandular Cell Neoplasm altered in cohorts of …ALTERED_INderived200 of 1,214show all (up to 200) |
|---|
| ← altered in cohorts of | CD40 151 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HNF4A 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCK1 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RIMS4 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SGK2 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRPC4AP 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BLCAP 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BMP7 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BPI 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BPIFB3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COX4I2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EDN3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EMILIN3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM83D 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXS1 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GCNT7 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HM13 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MROH8 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYL9 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIGT 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBM39 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPN2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC35C2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC9A8 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPO11 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SUN5 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADIG 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C20orf173 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNBD2 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPPIN-WFDC6 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ERGIC3 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM209B 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM210B 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAFB 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MMP24 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OSBPL2 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OSER1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAE1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RTF2 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SERINC3 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNAI1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TP53RK 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VAPB 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WFDC11 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WFDC13 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WFDC3 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL7A1 450 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 4 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | GLB1 450 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLXNB1 450 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATRIP 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC51 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDC25A 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CELSR3 449 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 2 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXW12 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HHATL 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IP6K2 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCKIPSD 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PFKFB4 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRKAR2A 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTH1R 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCN5A 449 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 4 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | SHISA5 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC26A6 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMA7 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM89 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TREX1 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UCN2 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UQCRC1 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VIPR1 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABHD14A 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABHD14A-ACY1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABHD14B 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABHD5 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACY1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ALAS1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANO10 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APEH 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARIH2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BSN 448 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 2 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | C3orf62 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C3orf84 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CAMP 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC13 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC71 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCRL2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DAG1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DALRD3 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DCAF1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DOCK3 448 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 4 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | DUSP7 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GNAI2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR62 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPX1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IHO1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCF1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCF2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCF3 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCF5 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHDC8B 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL40 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LAMB2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LARS2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIMD1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LTF 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MST1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NDUFAF3 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NICN1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NKTR 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NME6 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | P4HTM 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PARP3 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCBP4 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDCD6IP 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POC1A 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTPN23 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | QARS1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | QRICH1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL29 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RRP9 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCN11A 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC22C 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC25A20 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNRK 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPCS1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPINK8 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SS18L2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SUSD5 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TCTA 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TLR9 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TOPAZ1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP19 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP4 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WDR6 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | XIRP1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBTB47 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF589 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF620 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DIDO1 345 / 461 cases (75 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APC 5,400 / 7,237 cases (75 %) · ssm · crc_msk_2026 · largest of 17 cohorts | — | — | Rectal Adenocarcinoma | 17 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KCNB1 343 / 461 cases (74 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | LAMA5 340 / 461 cases (74 %) · ssm · TCGA-COAD · largest of 5 cohorts | — | — | Colon Adenocarcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | CHD6 339 / 461 cases (74 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC12A5 338 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TSHZ2 338 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | ZMYND8 338 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM189B 276 / 377 cases (73 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TP53 5,295 / 7,237 cases (73 %) · ssm · crc_msk_2026 · largest of 69 cohorts | — | — | Rectal Adenocarcinoma | 69 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH4 337 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | RALGAPB 337 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | DCST2 275 / 377 cases (73 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | EFNA1 275 / 377 cases (73 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | MTX1 275 / 377 cases (73 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBTB7B 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARFGEF2 336 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | NCOA6 336 / 461 cases (73 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARHGEF2 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DPM3 274 / 377 cases (73 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | EFNA4 274 / 377 cases (73 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | KHDC4 274 / 377 cases (73 %) · ssm · TCGA-LIHC · largest of 3 cohorts | — | — | Hepatocellular Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | KRTCAP2 274 / 377 cases (73 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | LENEP 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC1 274 / 377 cases (73 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNFX1 335 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | CEP250 334 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | DDX27 334 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNQ2 334 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SYCP2 334 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF335 334 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CKS1B 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DAP3 273 / 377 cases (72 %) · ssm · TCGA-LIHC · largest of 3 cohorts | — | — | Hepatocellular Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | PYGO2 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RXFP4 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHC1 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC27A3 273 / 377 cases (72 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | KIAA1755 333 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | LMNA 272 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MEX3A 272 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PMVK 272 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RYR2 413 / 573 cases (72 %) · ssm · TCGA-LUAD · largest of 23 cohorts | — | — | Lung Adenocarcinoma | 23 | Observed | gdc | graph → |
| ← altered in cohorts of | GNAS 332 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | HELZ2 332 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PREX1 332 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SALL4 332 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCT3 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ETV3L 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GATAD2B 271 / 377 cases (72 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ISG20L2 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LAMTOR2 271 / 377 cases (72 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC71 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MNDA 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NTRK1 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PMF1 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAB25 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEMA4A 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SH2D2A 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SSR2 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM79 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBE2Q1 271 / 377 cases (72 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | UBQLN4 271 / 377 cases (72 %) · ssm · TCGA-LIHC · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP9A 331 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |